Who owns ZNTL?
Institutional ownership of Zentalis Pharmaceuticals Inc. from Form 13F, Q2 2026
114 institutional managers reported holding Zentalis Pharmaceuticals Inc. (ZNTL) in Form 13F filings for Q2 2026, with 47,384,573 shares worth $229M. The largest reported holder was 5AM Venture Management, LLC. Managers that filed both quarters added a net 4,103,662 shares (+9.5%). 34 opened new positions and 19 sold out.
- Funds holding
- 114
- Value held
- $229M
- New / sold out
- 34 / 19
- Net shares, same filers
- +9.5%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ZNTL
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| 5AM Venture Management, LLC | $19.1M | 8.3% | 3,947,913 | Unchanged |
| BlackRock, Inc. | $18.2M | 7.9% | 3,753,525 | Added |
| Squadron Capital Management LLC | $17.9M | 7.8% | 3,700,000 | Added |
| Two Sigma Investments, LP | $14.7M | 6.4% | 3,024,936 | Added |
| Vanguard Capital Management LLC | $13.8M | 6.0% | 2,835,669 | Added |
| Acadian Asset Management LLC | $13.0M | 5.7% | 2,681,900 | Trimmed |
| Citadel Advisors LLC | $11.1M | 4.9% | 2,298,403 | Added |
| Renaissance Technologies LLC | $7.8M | 3.4% | 1,609,078 | Trimmed |
| Opaleye Management Inc. | $6.9M | 3.0% | 1,412,656 | Unchanged |
| Orbimed Advisors LLC | $6.7M | 2.9% | 1,390,576 | New |
| Decheng Capital LLC | $6.4M | 2.8% | 1,323,327 | Unchanged |
| Geode Capital Management, LLC | $6.2M | 2.7% | 1,284,117 | Added |
| Bank of America Corp | $5.4M | 2.4% | 1,114,650 | Trimmed |
| Ishara Investments LP | $5.0M | 2.2% | 1,025,000 | Trimmed |
| Primecap Management Co | $4.6M | 2.0% | 957,420 | Unchanged |
| Soleus Capital Management, L.P. | $4.6M | 2.0% | 950,000 | New |
| State Street Corp | $4.3M | 1.9% | 887,416 | Added |
| Vanguard Portfolio Management LLC | $3.9M | 1.7% | 808,548 | Added |
| Pfizer Inc | $3.9M | 2.0% | 953,834 | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | $3.7M | 1.6% | 758,033 | Trimmed |
| Millennium Management LLC | $3.2M | 1.4% | 664,281 | Trimmed |
| ADAR1 Capital Management, LLC | $3.2M | 1.4% | 652,750 | Added |
| Marshall Wace, LLP | $2.9M | 1.2% | 591,473 | Added |
| Qube Research & Technologies Ltd | $2.8M | 1.2% | 574,806 | Trimmed |
| D. E. Shaw & Co., Inc. | $2.7M | 1.2% | 546,566 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 47,384,573 ZNTL shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$12.0M
- Orbimed Advisors LLC New+$6.7M
- Soleus Capital Management, L.P. New+$4.6M
- Geode Capital Management, LLC Added+$3.2M
- State Street Corp Added+$3.1M
- Citadel Advisors LLC Added+$2.7M
- Vanguard Capital Management LLC Added+$2.5M
- ADAR1 Capital Management, LLC Added+$2.5M
- Vanguard Portfolio Management LLC Added+$2.2M
- Dimensional Fund Advisors LP Added+$1.3M
Biggest sellers in Q2 2026
- D. E. Shaw & Co., Inc. Trimmed-$4.5M
- Millennium Management LLC Trimmed-$3.0M
- Jane Street Group, LLC Trimmed-$2.3M
- BNP Paribas Financial Markets Trimmed-$2.2M
- Barclays PLC Trimmed-$2.1M
- Susquehanna International Group, LLP Trimmed-$1.7M
- Renaissance Technologies LLC Trimmed-$1.6M
- Almitas Capital LLC Sold out-$1.4M
- Gsa Capital Partners LLP Trimmed-$1.2M
- Ishara Investments LP Trimmed-$994K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $52.8M and sold $28.9M; 29 added and 32 trimmed.
Schedule 13D and 13G filings on ZNTL
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-30BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-11-12BARCLAYS PLC SCHEDULE 13G filed by Zentalis Pharmaceuticals Inc.Schedule 13G
- 2025-02-04MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Zentalis Pharmaceuticals Inc.Schedule 13G
Questions about ZNTL ownership
- Who owns ZNTL stock?
- 114 institutional investment managers reported ZNTL positions in their Form 13F filings for Q2 2026, holding 47,384,573 shares worth $229M in total. 5AM Venture Management, LLC reported the largest position.
- Are funds buying or selling ZNTL?
- In Q2 2026, 34 managers opened new ZNTL positions, 29 added, 32 trimmed and 19 sold out. Managers that filed in both quarters added a net 4,103,662 shares.
- How current is this ZNTL institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ZNTL by CUSIP. Options are left out. ZNTL news and filings · ZNTL insider trades · Top funds